Jefferies analyst Maury Raycroft initiates coverage on Vera Therapeutics (NASDAQ: VERA) at Buy, target $27
https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Jefferies+Starts+Vera+Therapeutics+%28VERA%29+at+Buy/18531278.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.